Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

April 15, 2022

Study Completion Date

May 20, 2022

Conditions
Influenza, Human
Interventions
DIAGNOSTIC_TEST

Procalcitonin

Procalcitonin is a blood test used to differentiate between viral and bacterial infections. This test is expected to aid in determining the best course of treatment for patients enrolled into this arm.

OTHER

Pharmacist-Led Education

Pharmacists will interpret the results of the Roche Cobas Liat Flu/RSV assay and procalcitonin test (if available) and provide the treating physician with recommendations for antibiotic therapy based on these results.

Trial Locations (1)

95817

University of California, Davis Medical Center, Sacramento

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

University of California, Davis

OTHER

NCT02899065 - Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department | Biotech Hunter | Biotech Hunter